Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 3
2008 12
2009 18
2010 32
2011 47
2012 60
2013 81
2014 79
2015 75
2016 80
2017 71
2018 49
2019 69
2020 72
2021 60
2022 55
2023 36
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

766 results

Results by year

Filters applied: . Clear all
Page 1
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach.
Hoke ATK, Takahashi Y, Padget MR, Gomez J, Amit M, Burks J, Bell D, Xie T, Soon-Shiong P, Hodge JW, Hanna EY, London NR Jr. Hoke ATK, et al. Transl Oncol. 2024 Jun;44:101943. doi: 10.1016/j.tranon.2024.101943. Epub 2024 Apr 10. Transl Oncol. 2024. PMID: 38593586 Free PMC article.
Patients with higher CD3(+)CD8(+) in the stroma had a significantly improved 5-year overall survival (P = 0.0029) and a significant increase in CK(low) tumor cell/CD8(+) cytotoxic T cell interactions was noted in long-term survivors (P = 0.0225). CONCLUSION: These data pro …
Patients with higher CD3(+)CD8(+) in the stroma had a significantly improved 5-year overall survival (P = 0.0029) and a significant increase …
Iterative Patient Testing of a Stimuli-Responsive Swallowing Activity Sensor to Promote Extended User Engagement During the First Year After Radiation: Multiphase Remote and In-Person Observational Cohort Study.
Shinn EH, Garden AS, Peterson SK, Leupi DJ, Chen M, Blau R, Becerra L, Rafeedi T, Ramirez J, Rodriquez D, VanFossen F, Zehner S, Mercier PP, Wang J, Hutcheson K, Hanna E, Lipomi DJ. Shinn EH, et al. JMIR Cancer. 2024 Feb 28;10:e47359. doi: 10.2196/47359. JMIR Cancer. 2024. PMID: 38416544 Free PMC article.
OBJECTIVE: We iteratively assessed patients' design preferences and perceived barriers to long-term use of the prototype sensor. METHODS: In study 1 (questionnaire only), survivors of pharyngeal cancer who were 3-5 years post treatment and part of a larger prospective stud …
OBJECTIVE: We iteratively assessed patients' design preferences and perceived barriers to long-term use of the prototype sensor. METH …
A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus.
Kumaresan PR, Wurster S, Bavisi K, da Silva TA, Hauser P, Kinnitt J, Albert ND, Bharadwaj U, Neelapu S, Kontoyiannis DP. Kumaresan PR, et al. mBio. 2024 Apr 10;15(4):e0341323. doi: 10.1128/mbio.03413-23. Epub 2024 Feb 28. mBio. 2024. PMID: 38415653 Free PMC article.
In conclusion, we developed a novel lentiviral strategy to obtain AF-CAR T cells with high targeting efficacy, yielding significant anti-AF activity in vitro and short-term protection in vivo. Our approach could serve as an important steppingstone for future clinical trans …
In conclusion, we developed a novel lentiviral strategy to obtain AF-CAR T cells with high targeting efficacy, yielding significant anti-AF …
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Khouri IF, Alzahrani K, Kantarjian H, Milton DR, Gulbis AM, Sasaki K, Jain N, Short NJ, Kadia T, Daher M, Rafei H, Im JS, Marin D, Olson AL, Popat U, Qazilbash M, Ramdial J, Rondon G, Srour S, Kebriaei P, Shpall E, Champlin R, Jabbour EJ. Khouri IF, et al. Am J Hematol. 2024 May;99(5):836-843. doi: 10.1002/ajh.27254. Epub 2024 Feb 23. Am J Hematol. 2024. PMID: 38400519 Clinical Trial.
Here we report on the first prospective study evaluating the safety and long-term survival when an escalating dose of inotuzumab ozogamicin (INO) (0.6, 1.2, or 1.8 mg/m(2) on day 13) was added to one alkylator-containing conditioning regimen in patients with relapsed CD22 …
Here we report on the first prospective study evaluating the safety and long-term survival when an escalating dose of inotuzumab ozog …
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.
Shin DH, Jiang H, Gillard AG, Kim D, Fan X, Singh SK, Nguyen TT, Sohoni SS, Lopez-Rivas AR, Parthasarathy A, Ene CI, Gumin J, Lang FF, Alonso MM, Gomez-Manzano C, Fueyo J. Shin DH, et al. Mol Ther. 2024 Mar 6;32(3):722-733. doi: 10.1016/j.ymthe.2024.01.035. Epub 2024 Feb 3. Mol Ther. 2024. PMID: 38311852 Free article.
Data from a previous clinical trial using the oncolytic adenovirus Delta-24-RGD showed that generation of anti-viral neutralizing antibodies may affect the long-term survival of glioma patients. Past studies have examined the effects of neutralizing antibodies during syste …
Data from a previous clinical trial using the oncolytic adenovirus Delta-24-RGD showed that generation of anti-viral neutralizing antibodies …
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial.
Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash SM, Petrosino JF, Scheet P, Daniel CR. Zhang X, et al. EBioMedicine. 2023 Dec;98:104873. doi: 10.1016/j.ebiom.2023.104873. Epub 2023 Nov 30. EBioMedicine. 2023. PMID: 38040541 Free PMC article. Clinical Trial.
This study was registered on ClinicalTrials.gov as NCT02843425, recruitment is complete and long-term follow-up continues. FINDINGS: Of the 55 patients randomized by intervention sequence, 87% completed the 16-week trial, demonstrating an increase on-intervention in divers …
This study was registered on ClinicalTrials.gov as NCT02843425, recruitment is complete and long-term follow-up continues. FINDINGS: …
Rural racial disparities and barriers in mammography utilization among Medicare beneficiaries in Texas: A longitudinal study.
Liu Z, Shan Y, Kuo YF, Giordano SH. Liu Z, et al. Geriatr Nurs. 2024 Jan-Feb;55:14-20. doi: 10.1016/j.gerinurse.2023.10.019. Epub 2023 Nov 13. Geriatr Nurs. 2024. PMID: 37967477 Free PMC article.
This study examined rural racial/ethnic disparities in long-term mammography screening practices among Medicare beneficiaries. ...
This study examined rural racial/ethnic disparities in long-term mammography screening practices among Medicare beneficiaries. ...
Examining the Association between Abstinence from Smoking and Healthcare Costs Among Patients with Cancer.
Kypriotakis G, Kim S, Karam-Hage M, Robinson JD, Minnix JA, Blalock JA, Cui Y, Beneventi D, Kim B, Pan IW, Shih YT, Cinciripini PM. Kypriotakis G, et al. Cancer Prev Res (Phila). 2023 Nov 8. doi: 10.1158/1940-6207.CAPR-23-0245. Online ahead of print. Cancer Prev Res (Phila). 2023. PMID: 37940143
Sensitivity analysis corroborated these conclusions, showing a pronounced cost reduction when outlier data were excluded. The long-term accrued cost savings from smoking cessation could potentially offset the cost of participation in the TRTP program, underscoring its cost …
Sensitivity analysis corroborated these conclusions, showing a pronounced cost reduction when outlier data were excluded. The long-term …
Methacrylated poly(glycerol sebacate) as a photocurable, biocompatible, and biodegradable polymer with tunable degradation and drug release kinetics.
Bice ML, Ortega VL, Yu MH, McHugh KJ. Bice ML, et al. Res Sq [Preprint]. 2023 Oct 6:rs.3.rs-3384762. doi: 10.21203/rs.3.rs-3384762/v1. Res Sq. 2023. PMID: 37886600 Free PMC article. Preprint.
Like PGS, PGS-M exhibited good biocompatibility, eliciting limited inflammation and fibrous encapsulation when implanted subcutaneously. These studies are the first to perform long-term studies demonstrating the ability to tune PGS-M degradation rate, use PGS-M to release …
Like PGS, PGS-M exhibited good biocompatibility, eliciting limited inflammation and fibrous encapsulation when implanted subcutaneously. The …
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy.
Bulliard Y, Andersson BS, Baysal MA, Damiano J, Tsimberidou AM. Bulliard Y, et al. J Hematol Oncol. 2023 Oct 25;16(1):108. doi: 10.1186/s13045-023-01504-7. J Hematol Oncol. 2023. PMID: 37880715 Free PMC article. Review.
T cell differentiation is a highly regulated, multi-step process necessary for the progressive establishment of effector functions, immunological memory, and long-term control of pathogens. In response to strong stimulation, as seen in severe or chronic infections or cance …
T cell differentiation is a highly regulated, multi-step process necessary for the progressive establishment of effector functions, immunolo …
766 results